KC Investor in Ireland Firm Schedules Investor Conference Call
A Kansas City investor in an Ireland-based firm has scheduled an investor conference call to discuss a proposal to remove the existing directors:
Thomas Reidy, an investor in Trinity Biotech plc (Nasdaq: TRIB), an Ireland-based developer and manufacturer of diagnostic products whose American Depository Receipts are traded on NASDAQ, will host an investor conference call November 3, 2008, at 10:00am EST, to discuss the recent shareholder proposal calling for the removal and replacement of Trinity Biotech’s current directors.
The conference call can be accessed in the U.S. by dialing 1-800-899-9949 conference code 2111155.
More Ireland KC Business News:
• Bombardier’s Irish Incentives Scrutinized After KC Failure
• Irish Renewable Energy Company Backs Missouri Wind Farm Company
• Irish Firm to Double Employment in Lawrence, KS
Eolaí gan Fhéile:
